Conclusions
This study proved the efficacy of corticosteroid injection and surgical release in treatment of persistent DQST. The most important fact gained from the present study is that the outcomes after injection treatment were similar to those after surgical release, and there was an insignificant difference between the two methods. Accordingly, injection is preferred over release because it requires no hospitalization, no anesthesia risk, much less cost, easier application, no soft-tissue dissection, and no surgical complications such as scarring, keloid formation, or tendon subluxation. Therefore, the authors recommend the use of corticosteroid injection for initial treatment of persistent DQST and reserve invasive surgical release for patients who fail to respond to maximum injections.
Financial disclosure
The authors declare no conflicts of interest.
Curr Orthop Pract. 2022;33(1):27-31. © 2022 Lippincott Williams & Wilkins
